World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
90
Citations
26440
World Ranking
2466
National Ranking
172

Research.com Recognitions

  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Member of the European Molecular Biology Organization (EMBO)
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Member of the European Molecular Biology Organization (EMBO)
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Member of the European Molecular Biology Organization (EMBO)

Overview

Paul J. Lehner is affiliated with the University of Cambridge in the United Kingdom. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions focused on Infectious Diseases, Molecular Biology, Immunology, Epidemiology, and Neurology.

The scientist's work covers a range of topics including SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, long-term effects of COVID-19, CRISPR and genetic engineering, interferon and immune responses, herpesvirus infections and treatments, and cytomegalovirus and herpesvirus research.

Among their recent publications are:

  • Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity (2022, Nature)
  • SARS-CoV-2 evolution during treatment of chronic infection (2021, Nature)
  • Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2 (2021, Nature)
  • Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies (2021, Nature)
  • Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease (2021, Immunity)

The scientist has frequently collaborated with researchers including Nicholas J. Matheson, Paul Lyons, James C. Williamson, Michael P. Weekes, and John R. Bradley, with each co-author contributing to numerous joint publications.

Frequent publication venues for Paul J. Lehner include bioRxiv (Cold Spring Harbor Laboratory), Nature Communications, Nature, eLife, and SSRN Electronic Journal.

Paul J. Lehner has been recognized as a Member of the European Molecular Biology Organization (EMBO) and as a Fellow of The Academy of Medical Sciences in the United Kingdom.

Best Publications

  • SARS-CoV-2 evolution during treatment of chronic infection.

    Steven A. Kemp;Dami A. Collier;Dami A. Collier;Rawlings P. Datir;Isabella A. T. M. Ferreira

  • CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

    Marian L Burr;Marian L Burr;Marian L Burr;Christina E Sparbier;Yih-Chih Chan;James C Williamson

  • Roles for Calreticulin and a Novel Glycoprotein, Tapasin, in the Interaction of MHC Class I Molecules with TAP

    Bhanu Sadasivan;Paul J Lehner;Bodo Ortmann;Thomas Spies

  • Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.

    Dami A Collier;Dami A Collier;Isabella A T M Ferreira;Prasanti Kotagiri;Rawlings P Datir;Rawlings P Datir

  • A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes.

    Bodo Ortmann;James Copeman;Paul J. Lehner;Bhanu Sadasivan

  • Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.

    Dami A. Collier;Dami A. Collier;Anna De Marco;Isabella A. T. M. Ferreira;Bo Meng

  • Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission.

    Lucy Rivett;Lucy Rivett;Sushmita Sridhar;Sushmita Sridhar;Dominic Sparkes;Dominic Sparkes;Matthew Routledge;Matthew Routledge

  • Quantitative temporal viromics: an approach to investigate host-pathogen interaction.

    Michael P. Weekes;Michael P. Weekes;Peter Tomasec;Edward L. Huttlin;Ceri Alan Fielding

  • Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers.

    M. B. Reeves;P. A. MacAry;P. J. Lehner;J. G. P. Sissons

  • An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer

    Marian L. Burr;Marian L. Burr;Marian L. Burr;Christina E. Sparbier;Christina E. Sparbier;Kah Lok Chan;Kah Lok Chan;Yih-Chih Chan

  • NOTCH1 mediates a switch between two distinct secretomes during senescence

    Matthew William Hoare;Yoko Ito;Tae-Won Kang;Michael Paul Weekes

  • Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts.

    R Andres Floto;Menna R Clatworthy;Karen R Heilbronn;Dalya R Rosner

  • The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation

    Paul J. Lehner;Jaana T. Karttunen;Gavin W. G. Wilkinson;Peter Cresswell

  • Soluble Tapasin Restores MHC Class I Expression and Function in the Tapasin-Negative Cell Line .220

    Paul J Lehner;Michael J Surman;Peter Cresswell

  • CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines.

    Yufei Wang;Charles G. Kelly;Jaana T. Karttunen;Trevor Whittall

  • Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules.

    Lidia M Duncan;Siân Piper;Roger B Dodd;Mark K Saville

  • Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.

    Laura Bergamaschi;Federica Mescia;Lorinda Turner;Aimee L. Hanson

  • Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment.

    Paul J. Lehner;Eddie C. Y. Wang;Paul A. H. Moss;Sheila Williams

  • Epigenetic silencing by the HUSH complex mediates position-effect variegation in human cells

    Iva A. Tchasovnikarova;Richard T. Timms;Nicholas J. Matheson;Kim Wals

  • Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses.

    Philip G. Stevenson;Stacey Efstathiou;Peter C. Doherty;Paul J. Lehner

Frequent Co-Authors

Robin Antrobus
Robin Antrobus University of Cambridge
Gordon Dougan
Gordon Dougan University of Cambridge
Kenneth G. C. Smith
Kenneth G. C. Smith Walter and Eliza Hall Institute of Medical Research
Paul A. MacAry
Paul A. MacAry National University of Singapore
Ian Goodfellow
Ian Goodfellow University of Cambridge
Peter Cresswell
Peter Cresswell Yale University
Stephen Baker
Stephen Baker Agency for Science, Technology and Research
Paul A. Lyons
Paul A. Lyons University of Cambridge
M. Estée Török
M. Estée Török Bill & Melinda Gates Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Paul J. Lehner

Trending Scientists

Recently Published Articles